| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -21.13M | $ -15.79M | $ -22.73M | $ -17.93M | $ -36.93M |
| EBITDA | $ -18.18M | $ -16.62M | $ -21.66M | $ -18.85M | $ -35.53M |
| Net Income | $ -18.43M | $ -11.86M | $ -22.36M | $ -18.92M | $ -31.59M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 4.01M | $ 3.72M | $ 1.18M | $ 18.12M | $ 42.19M |
| Total Assets | $ 11.49M | $ 11.28M | $ 12.18M | $ 26.48M | $ 48.83M |
| Total Debt | $ 456.00K | $ 106.00K | $ 247.00K | $ 365.00K | $ 1.35M |
| Net Debt | $ -3.55M | $ -3.62M | $ -936.00K | $ -17.76M | $ -40.83M |
| Total Liabilities | $ 11.44M | $ 7.35M | $ 6.65M | $ 6.91M | $ 7.55M |
| Stockholders' Equity | $ 52.00K | $ 3.94M | $ 5.54M | $ 19.57M | $ 41.28M |
| Cash Flow | |||||
| Free Cash Flow | $ -12.87M | $ -1.23M | $ -12.42M | $ -15.99M | $ -16.15M |
| Operating Cash Flow | $ -12.85M | $ -1.22M | $ -12.42M | $ -15.99M | $ -16.13M |
| Investing Cash Flow | $ 3.04M | $ -56.73K | $ -991.57K | $ -3.26M | $ 96.36K |
| Financing Cash Flow | $ 10.01M | $ 3.60M | $ 31.65K | $ -44.84K | $ -17.05K |
Tiziana Life Sciences Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.